21.38
-0.47%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Apeloa Pharmaceutical Co
Its shares trade on Shenzhen under the ticker 000739.SZ. It has been listed since 9 May 1997. In the fiscal year to 31 December 2025, it reported revenue of CN¥9.76bn and net income of CN¥890.7m. At that date it held total assets of CN¥12.32bn and shareholders' equity of CN¥6.34bn.
Apeloa Pharmaceutical Co., Ltd. engages in research, development, and production of active pharmaceutical ingredient (API) intermediates, contract development and production services (CDMO), and preparations. The company is headquartered in Jinhua, Zhejiang. The Company’s main products consist of bulk drugs, intermediates, chemical preparations, as well as Chinese traditional medicine preparations, such as ubenimex capsules, cefixime, amantadine and others. The firm distributes its businesses in domestic market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 9 May 1997
- Employees
- 6,791
- Website
- apeloa.com ↗
Leadership
Pay as last reported
- Mr. Fangmeng ZhuChairman of the Board, since 2012CN¥2.6m
- Mr. Xinliang XuVice Chairman of the Board, since 2005CN¥1.6m
- Mr. Jinhui ZhangChief Financial OfficerCN¥830,600
- Mr. Chun HeGeneral ManagerCN¥1.2m
- Mr. Yuwang ZhouDeputy General Manager, Secretary of the BoardCN¥729,500
- Mr. Lei CaiDeputy General ManagerCN¥810,000
- Mr. Min JinSenior Deputy General ManagerCN¥1.2m
- Mr. Tiangao HuDirector
- Mr. Wencai XuDirector, since 2001
- Mr. Ling ChenIndependent DirectorCN¥100,000
- Mr. Weiguang PanIndependent DirectorCN¥100,000
- Ms. Juanping QianIndependent DirectorCN¥100,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 58
- Environment
- 95
- Social
- 47
- Governance
- 32
- Direct emissions (scope 1)
- 10,400 t
- Energy emissions (scope 2)
- 605,200 t
- Women in the workforce
- 39.7%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Apeloa Pharmaceutical Co Ltd employs 6,791 full-time employees in Jinhua, Zhejiang.
- Apeloa produces bulk drugs, intermediates, and Chinese traditional medicine preparations like ubenimex capsules.
- Apeloa offers CDMO services and distributes products domestically and overseas.
Weaknesses
- Apeloa's headquarters is in Jinhua, Zhejiang, which may limit global reach.
- Apeloa's business is concentrated in the Health Care sector without diversification.
- Apeloa's products include traditional medicine, which may face regulatory challenges.
Opportunities
- Apeloa can expand CDMO services to meet growing global pharmaceutical demand.
- Apeloa can leverage Chinese traditional medicine preparations for international markets.
- Apeloa can increase exports to overseas markets beyond current distribution.
Threats
- Apeloa faces competition from other pharmaceutical companies in the Health Care sector.
- Apeloa's reliance on bulk drugs may be affected by fluctuating raw material costs.
- Apeloa's traditional medicine products may encounter regulatory hurdles in foreign markets.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.